BRIEF-Spero Therapeutics to acquire worldwide rights to Vertex's VXC-486/VXC-100 By: Reuters: Company News May 25, 2016 at 08:20 AM EDT * Deal to acquire worldwide rights to VXC-486/VXC-100 and a portfolio of innovative antibacterial compounds Read More >> Related Stocks: Vertex Pharmaceuticals